Page 53 - Sheppard Mullin 2015 Silicon Valley Annual Review
P. 53
2015 Matters | Lorna Tanner
• Gilead Sciences, Inc. - Prosecuting numerous pat- ent portfolios directed to hepatitis C and cardiovas- cular approved drugs and drugs in development.
• Portola Pharmaceuticals, Inc. – Developing and prosecuting patents directed to anticoagulant drugs and biologics.
• Plexxikon Inc. – Developing and prosecuting pat- ents directed to oncology drugs and drug candi- dates.
• Continues to advise several Bay Area venture- backed biopharmaceutical companies in San Francisco and South San Francisco on their patent portfolio development and procurement strategies.
Life Sciences
50
